Gene · 6007
Papers4,511
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 4,511
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Liver Dysfunction with Severe Cholestasis and Coagulation Disorders in the Course of Hemolytic Disease of the Newborn Requiring Chelation Therapy-A Case Report and Review of the Literature. | J Clin Med | 2023 | 38137714 | PubTator, text mining | PubMed |
Impact of the ABO and RhD Blood Groups on the Evaluation of the Erythroprotective Potential of Fucoxanthin, β-Carotene, Gallic Acid, Quercetin and Ascorbic Acid as Therapeutic Agents against Oxidative Stress. | Antioxidants (Basel) | 2023 | 38136212 | PubTator, text mining | PubMed |
| Genotype analysis to clarify RhD variants in discrepant samples of Chilean population. | Front Immunol | 2023 | 38116010 | PubTator, text mining | PubMed |
| Case report: Genetic analysis of a novel intronic inversion variant in the SPTB gene associated with hereditary spherocytosis. | Front Genet | 2023 | 38111681 | PubTator, text mining | PubMed |
| MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targeting. | Nat Commun | 2023 | 38102140 | PubTator, text mining | PubMed |
| Advancing biological investigations using portable sensors for detection of sensitive samples. | Heliyon | 2023 | 38089995 | PubTator, text mining | PubMed |
| Rapid Identification of Seven Common ABO Alleles by Two-Dimensional Polymerase Chain Reaction Technology. | Transfus Med Hemother | 2023 | 38089490 | PubTator, text mining | PubMed |
| Knockout of the inhibitory receptor TIGIT enhances the antitumor response of ex vivo expanded NK cells and prevents fratricide with therapeutic Fc-active TIGIT antibodies. | J Immunother Cancer | 2023 | 38081778 | PubTator, text mining | PubMed |
| [Investigation of Antigen and Gene Frequency of Kell(K) and Rh(D) Blood Groups in Xinjiang]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2023 | 38071068 | PubTator, text mining | PubMed |
| Immunomodulation of Antibody Glycosylation through the Placental Transfer. | Int J Mol Sci | 2023 | 38069094 | PubTator, text mining | PubMed |
| Effect of RhD and RhE sample phenotypic blood transfusion on the prognosis of hepatocellular carcinoma. | Medicine (Baltimore) | 2023 | 38065917 | PubTator, text mining | PubMed |
| Pectin a multifaceted biopolymer in the management of cancer: A review. | Heliyon | 2023 | 38058641 | PubTator, text mining | PubMed |
| The frequency of ABO and Rhesus(D) blood group antigens among blood transfused patients in Northern Ethiopia, 2023: Retrospective study. | Heliyon | 2023 | 38045168 | PubTator, text mining | PubMed |
| Advancing cell surface modification in mammalian cells with synthetic molecules. | Chem Sci | 2023 | 38033886 | PubTator, text mining | PubMed |
| Clinical response to therapeutic plasmapheresis and intravenous immunoglobulin in pregnancies complicated by alloimmunization despite persistently high titers: Report of two cases. | Clin Case Rep | 2023 | 38028069 | PubTator, text mining | PubMed |
| A comparative analysis of current out-of-hospital transfusion protocols to expert recommendations. | Resusc Plus | 2023 | 38026143 | PubTator, text mining | PubMed |
| Role and therapeutic potential of DEAD-box RNA helicase family in colorectal cancer. | Front Oncol | 2023 | 38023215 | PubTator, text mining | PubMed |
| Chronic Abruptio Placentae With Multiple Alloantibodies: An Obstetrician's Challenge. | Cureus | 2023 | 38021680 | PubTator, text mining | PubMed |
| Differentiation-dependent chromosomal organization changes in normal myogenic cells are absent in rhabdomyosarcoma cells. | Front Cell Dev Biol | 2023 | 38020905 | PubTator, text mining | PubMed |
| Distribution of ABO and rhesus blood grouping with HIV infection among blood donors in Ekiti State Nigeria. | Medicine (Baltimore) | 2023 | 38013335 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6007/papers?page=22